Bridgeway Capital Management’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167K | Hold |
134,300
| – | – | ﹤0.01% | 996 |
|
|
2025
Q1 | $164K | Buy |
+134,300
| New | +$164K | ﹤0.01% | 958 |
|
|
2024
Q3 | – | Sell |
-55,223
| Closed | -$393K | – | 1327 |
|
|
2024
Q2 | $393K | Hold |
55,223
| – | – | 0.01% | 917 |
|
|
2024
Q1 | $151K | Hold |
55,223
| – | – | ﹤0.01% | 1152 |
|
|
2023
Q4 | $148K | Hold |
55,223
| – | – | ﹤0.01% | 1188 |
|
|
2023
Q3 | $146K | Hold |
55,223
| – | – | ﹤0.01% | 1153 |
|
|
2023
Q2 | $155K | Hold |
55,223
| – | – | ﹤0.01% | 1184 |
|
|
2023
Q1 | $160K | Hold |
55,223
| – | – | ﹤0.01% | 1142 |
|
|
2022
Q4 | $198K | Hold |
55,223
| – | – | 0.01% | 1092 |
|
|
2022
Q3 | $178K | Buy |
55,223
+34,800
| +170% | +$112K | ﹤0.01% | 1161 |
|
|
2022
Q2 | $62K | Buy |
20,423
+2,023
| +11% | +$6.14K | ﹤0.01% | 1272 |
|
|
2022
Q1 | $154K | Buy |
+18,400
| New | +$154K | ﹤0.01% | 1210 |
|